Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, CA, USA ; Department of Orthopaedic Surgery, Federal University of São Paulo, São Paulo, Brazil.
Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, CA, USA ; Department of Orthopaedic Surgery, Balikesir University, Balikesir, Turkey.
Cartilage. 2015 Apr;6(2):98-105. doi: 10.1177/1947603514566298.
The objective of this study was to assess the outcome of osteochondral allograft (OCA) transplantation as a salvage procedure after various cartilage repair surgeries.
One hundred sixty-four knees in 163 patients (mean age = 32.6 years; range = 11-59 years; 55% males) were treated with OCA transplantation after subchondral marrow stimulation (SMS), osteochondral autograft transplantation (OAT), and autologous chondrocyte implantation (ACI). The majority of previous procedures were isolated SMS in 145 knees (88.4%). Mean allograft size was 8.5 ± 7.9 cm(2). The most common location was in femoral condyle. The number and type of reoperations on the operative knee were assessed. Failure of the OCA transplantation was defined as any reoperation resulting in removal of the allograft. Functional outcomes were evaluated.
Sixty-eight knees had reoperations after OCA transplantation. Thirty-one knees (18.9%) were classified as allograft failures. The median time to failure was 2.6 ± 6.8 years (range = 0.7-23.4 years). Survivorship of the graft was 82% at 10 years and 74.9% at 15 years. Patients whose grafts were still in situ had a mean of 8.5 ± 5.6 years of follow-up. Scores on all functional outcomes scales improved significantly from preoperatively to latest follow-up. Eighty-nine percent of OCA transplantation patients reported being "extremely satisfied" or "satisfied."
Despite the high reoperation rate, OCA transplantation is a successful salvage surgical treatment after cartilage repair procedures. This cohort showed improved survivorship and functional outcomes of OCA transplantation after SMS, ACI, and OAT.
本研究旨在评估同种异体骨软骨移植(OCA)作为各种软骨修复手术后的挽救性治疗的结果。
163 例患者的 164 膝(平均年龄=32.6 岁;范围=11-59 岁;男性占 55%)接受同种异体骨软骨移植(OCA)治疗,这些患者先前接受过软骨下骨髓刺激术(SMS)、骨软骨自体移植术(OAT)和自体软骨细胞植入术(ACI)治疗。在 145 膝(88.4%)中,以前的手术多为单独的 SMS。平均移植物大小为 8.5±7.9cm2。最常见的部位是股骨髁。评估了手术膝关节的再手术次数和类型。将 OCA 移植的失败定义为任何导致移植物移除的再手术。评估了功能结果。
68 膝在 OCA 移植后进行了再次手术。31 膝(18.9%)被归类为移植物失败。失败的中位时间为 2.6±6.8 年(范围=0.7-23.4 年)。10 年时移植物存活率为 82%,15 年时为 74.9%。移植物仍在位的患者的平均随访时间为 8.5±5.6 年。所有功能结果评分均从术前到随访末期显著改善。89%的 OCA 移植患者报告“非常满意”或“满意”。
尽管再手术率较高,但 OCA 移植是软骨修复手术后的一种成功的挽救性治疗方法。该队列显示,在 SMS、ACI 和 OAT 后,同种异体骨软骨移植的存活率和功能结果均得到改善。